ANVS
Price
$2.31
Change
-$0.12 (-4.94%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
59.8M
129 days until earnings call
Intraday BUY SELL Signals
IGC
Price
$0.35
Change
-$0.02 (-5.41%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
33.66M
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANVS vs IGC

Header iconANVS vs IGC Comparison
Open Charts ANVS vs IGCBanner chart's image
Annovis Bio
Price$2.31
Change-$0.12 (-4.94%)
Volume$404
Capitalization59.8M
IGC Pharma
Price$0.35
Change-$0.02 (-5.41%)
Volume$100
Capitalization33.66M
ANVS vs IGC Comparison Chart in %
ANVS
Daily Signal:
Gain/Loss:
IGC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANVS vs. IGC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and IGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ANVS: $2.43 vs. IGC: $0.37)
Brand notoriety: ANVS and IGC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 228% vs. IGC: 50%
Market capitalization -- ANVS: $59.8M vs. IGC: $32.74M
ANVS [@Biotechnology] is valued at $59.8M. IGC’s [@Biotechnology] market capitalization is $32.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileIGC’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • IGC’s FA Score: 0 green, 5 red.
According to our system of comparison, IGC is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 6 TA indicator(s) are bullish while IGC’s TA Score has 3 bullish TA indicator(s).

  • ANVS’s TA Score: 6 bullish, 2 bearish.
  • IGC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than IGC.

Price Growth

ANVS (@Biotechnology) experienced а +19.12% price change this week, while IGC (@Biotechnology) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ANVS is expected to report earnings on Mar 23, 2026.

IGC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANVS($59.8M) has a higher market cap than IGC($33.7M). IGC YTD gains are higher at: 8.929 vs. ANVS (-51.690). IGC has higher annual earnings (EBITDA): -6.36M vs. ANVS (-23.68M). ANVS has more cash in the bank: 17.1M vs. IGC (454K). IGC has higher revenues than ANVS: IGC (1.33M) vs ANVS (0).
ANVSIGCANVS / IGC
Capitalization59.8M33.7M177%
EBITDA-23.68M-6.36M372%
Gain YTD-51.6908.929-579%
P/E RatioN/AN/A-
Revenue01.33M-
Total Cash17.1M454K3,767%
Total DebtN/A202K-
FUNDAMENTALS RATINGS
IGC: Fundamental Ratings
IGC
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSIGC
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signal:
Gain/Loss:
IGC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBVA21.830.38
+1.77%
Banco Bilbao Vizcaya Argentaria SA
OLED120.921.55
+1.30%
Universal Display Corp
BRY3.40-0.04
-1.16%
Berry Corp
RES5.50-0.18
-3.17%
RPC
BEEM1.86-0.28
-13.08%
Beam Global

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+15.17%
ADXN - ANVS
43%
Loosely correlated
N/A
RXRX - ANVS
38%
Loosely correlated
-1.27%
VYGR - ANVS
37%
Loosely correlated
-0.23%
BDTX - ANVS
37%
Loosely correlated
+5.41%
ATXS - ANVS
37%
Loosely correlated
+0.32%
More

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-5.35%
TECX - IGC
49%
Loosely correlated
-0.63%
ANVS - IGC
30%
Poorly correlated
+15.17%
ARTL - IGC
29%
Poorly correlated
-8.16%
KZR - IGC
28%
Poorly correlated
-0.32%
CRBU - IGC
28%
Poorly correlated
+0.89%
More